---
title: "CONBA released its first-quarter performance, with a net profit attributable to the parent company of 189 million yuan, a year-on-year decrease of 12.34%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237813624.md"
description: "According to the Zhitong Finance APP, CONBA disclosed its first-quarter report for 2025, showing that the company achieved revenue of 1.685 billion yuan, a year-on-year decrease of 7.64%; net profit attributable to the parent company was 189 million yuan, a year-on-year decrease of 12.34%; and net profit excluding non-recurring gains and losses was 162 million yuan, a year-on-year decrease of 19.35%. Basic earnings per share were 0.075 yuan"
datetime: "2025-04-28T09:52:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237813624.md)
  - [en](https://longbridge.com/en/news/237813624.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237813624.md)
generator: "portal-rs"
---

# CONBA released its first-quarter performance, with a net profit attributable to the parent company of 189 million yuan, a year-on-year decrease of 12.34%

According to the Zhitong Finance APP, CONBA (600572.SH) disclosed its first-quarter report for 2025, showing that the company achieved revenue of 1.685 billion yuan, a year-on-year decrease of 7.64%; net profit attributable to shareholders was 189 million yuan, a year-on-year decrease of 12.34%; and net profit excluding non-recurring items was 162 million yuan, a year-on-year decrease of 19.35%. Basic earnings per share were 0.075 yuan

### Related Stocks

- [600572.CN](https://longbridge.com/en/quote/600572.CN.md)

## Related News & Research

- [REG - AstraZeneca PLC - AstraZeneca completes agreement for Zegfrovy](https://longbridge.com/en/news/297603898.md)
- [07:15 ETTranspire Bio to Participate in Upcoming Healthcare Investor Conferences During September](https://longbridge.com/en/news/297775966.md)
- [RISE Robotics Awarded $100,000 MassVentures Grant to Accelerate Commercialization of Beltdraulic Technology](https://longbridge.com/en/news/297642626.md)
- [NeuroThera Labs seeks FDA orphan drug status for adult Tourette treatment SCI-110](https://longbridge.com/en/news/297783543.md)
- [11:00 ETCovationBio's Xatryx® Mass Production On Spec, to Debut First Non‑Food Bio‑Based Athletic Insole at NW Materials Show in the U.S.](https://longbridge.com/en/news/297804526.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**